Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians
Open Access
- 4 December 2012
- journal article
- practice guideline
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 157 (11), 808-816
- https://doi.org/10.7326/0003-4819-157-11-201212040-00008
Abstract
Also available: Consumer Reports Patient Resource on High-Value Care for GERD Upper endoscopy is commonly used in the diagnosis and management of gastroesophageal reflux disease (GERD). Evidence demonstrates that it is indicated only in certain situations, and inappropriate use generates unnecessary costs and exposes patients to harms without improving outcomes. The Clinical Guidelines Committee of the American College of Physicians reviewed evidence regarding the indications for, and yield of, upper endoscopy in the setting of GERD, and to highlight how clinicians can increase the delivery of high-value health care. Upper endoscopy is indicated in men and women with heartburn and alarm symptoms (dysphagia, bleeding, anemia, weight loss, and recurrent vomiting). Upper endoscopy is indicated in men and women with: Typical GERD symptoms that persist despite a therapeutic trial of 4 to 8 weeks of twice-daily proton-pump inhibitor therapy. Severe erosive esophagitis after a 2-month course of proton-pump inhibitor therapy to assess healing and rule out Barrett esophagus. Recurrent endoscopy after this follow-up examination is not indicated in the absence of Barrett esophagus. History of esophageal stricture who have recurrent symptoms of dysphagia. Upper endoscopy may be indicated: In men older than 50 years with chronic GERD symptoms (symptoms for more than 5 years) and additional risk factors (nocturnal reflux symptoms, hiatal hernia, elevated body mass index, tobacco use, and intra-abdominal distribution of fat) to detect esophageal adenocarcinoma and Barrett esophagus. For surveillance evaluation in men and women with a history of Barrett esophagus. In men and women with Barrett esophagus and no dysplasia, surveillance examinations should occur at intervals no more frequently than 3 to 5 years. More frequent intervals are indicated in patients with Barrett esophagus and dysplasia.Keywords
This publication has 35 references indexed in Scilit:
- Sex Disparities in Cancer Incidence by Period and AgeCancer Epidemiology, Biomarkers & Prevention, 2009
- Epidemiology of Non-Erosive Reflux DiseaseDigestion, 2008
- Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic DatabaseGastrointestinal Endoscopy, 2008
- The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based ConsensusThe American Journal of Gastroenterology, 2006
- Epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut, 2005
- Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995International Journal of Cancer, 2002
- Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancerCancer Causes and Control, 2000
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaNew England Journal of Medicine, 1999
- Opposing time trends of peptic ulcer and reflux diseaseGut, 1998
- Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, MinnesotaGastroenterology, 1997